The Agentic AI Readiness Gap Is a Judgment Gap, Not a Data Gap
Pharma's agentic AI pilots keep working. Scaling them keeps stalling. The real bottleneck isn't data quality — it's who decides which HCP-facing moments belong to a machine and which don't.
Every conversation about agentic AI in pharma commercial operations eventually arrives at the same confession: the pilot worked. Then someone tries to scale it, and it doesn't.
That pattern showed up again this month at Axtria's Ignite 2026 event, where Ashish Kathuria, the company's Client Business Unit Leader, offered a reframe that's been circulating in commercial ops circles since: stop scoping agentic AI to a "function" and start scoping it to a "job." As he put it, deployment becomes manageable "when you scope an agent to a defined job rather than a broad function." It's a clean idea, and it's correct as far as it goes. But I'd push on it, because the hard part isn't writing the job description. It's knowing where the job boundary actually sits inside a live HCP conversation — and that's a judgment call, not a data engineering task.
Here's the pattern I keep seeing described the same way across three separate pieces of industry commentary this month: pilots succeed at narrow, well-bounded tasks — territory prioritization, call summarization, next-best-action suggestions — and then stall when organizations try to widen scope. The stated reasons are almost always the same three: the cost of scaling past a pilot, data that's too siloed or inconsistent to trust at volume, and a workforce-alignment problem — nobody has actually decided which tasks the agent owns and which stay human. IQVIA's own commentary on the 2026 shift, from analysis to action, frames the physician engagement piece almost identically: agentic AI is supposed to curate data and generate content so the human interaction can move from transactional to consultative. Everyone agrees on the shape. Almost nobody has defined, in operational terms, where transactional ends and consultative begins.
That line is the real bottleneck, and it's worth being precise about why. A "job" isn't a fixed task type — it's a judgment about what a given moment in a conversation requires. Confirming a formulary update is transactional right up until the physician's tone shifts and the real question underneath is about a patient case they're worried about. Summarizing a call is safe automation right up until the summary has to capture that the HCP's objection wasn't really about efficacy data — it was about something they didn't say directly. An agent scoped to "handle the transactional layer" is only as good as an organization's ability to recognize, in real time, when a transactional moment has quietly become a consultative one. That recognition is a human skill. It is not something you solve by cleaning up a data warehouse, and it's not something a broader agent mandate fixes either — it's the actual capability gap sitting underneath the deployment problem everyone's describing.
This is why I think the "Jobs-to-be-Done" reframe, useful as it is, undersells the difficulty. Scoping an agent to a job assumes the organization already has a shared, measurable understanding of where human judgment is strong and where it's shaky across its field force — moment by moment, not rep by rep in aggregate. Most commercial excellence functions don't have that. They have message adherence scores and call activity metrics. Those tell you whether the rep said the right thing. They don't tell you whether the rep noticed the moment that mattered, correctly read what was actually being asked, and responded in a way that matched the stakes. Without visibility into that layer, "scope the agent to a defined job" is a plan you can't actually execute with confidence — you're guessing at the boundary instead of measuring it.
The industry has spent the last decade getting very good at teaching the message: content libraries, call scripts, brand claims, all trainable and trackable. Scaling the judgment underneath those interactions — knowing when to deviate from the message because the human across the table needs something else in that moment — has never had the same measurement infrastructure. Agentic AI doesn't remove that gap. It raises the stakes on closing it, because now the cost of a wrong boundary isn't just a rep who improvises poorly. It's an agent that either automates a moment that needed a human, or holds back on a moment a human didn't need to spend time on.
Pharma doesn't have an agentic AI readiness gap so much as it has a judgment visibility gap wearing an AI-shaped costume. Fix the second problem and the first one gets much easier to scope honestly.
What would it take for your organization to say, with confidence, exactly where the human judgment line sits in your highest-stakes HCP conversations — not in aggregate, but moment by moment?
Sources: